Generic heart medication shown to prolong ovarian cancer patients' survival

In a first-of-its-kind study, researchers demonstrate a benefit in overall survival among epithelial ovarian cancer (EOC) patients receiving generic heart medications known as beta-blockers. 
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news